Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...

Founded in 2021, Colossal is best known for its controversial quest to revive extinct creatures such as the woolly mammoth, ...

The creation of the world's first "biovault" was announced this week, marking a new initiative that experts have likened to a ...

Scientists have announced plans to construct what they are calling a 'modern-day Noah's Ark' in Dubai that will serve as a ...

The Dallas-based genetics company and the UAE plan to store DNA from 100 of the most vulnerable species in a special lab in ...

Dallas de-extinction startup Colossal Biosciences announced a $60 million investment from the United Arab Emirates and the first location of its ...

During the Virtual Happy Hour, O’Hara said she learned about the condition more than 20 years ago. Situs inversus affects ...

The ARK Genomic Revolution ETF remains a "Buy" as it beats SPY/XLV, shows bullish breakout signals, and targets $42. Learn more about the fund.

Cathie Wood's ARK sold $2.78M Twist Bioscience, bought Tempus AI & WeRide Jan 26. Full breakdown of ARK Invest's latest AI ...

Cathie Wood’s ARK Invest broadly rotated its portfolios toward AI, autonomous driving, and healthcare tech names last week, ...

ARK Invest is planning two crypto index ETFs, one with Bitcoin and major altcoins, and one without Bitcoin. The ETFs will be listed on NYSE Arca, as Cathie Wood’s firm also invests in companies like ...